| scholarly article | Q13442814 |
| P2093 | author name string | H Horie | |
| S Saito | |||
| M Tsuyuguchi | |||
| Y Yokogoshi | |||
| P2860 | cites work | Two G protein oncogenes in human endocrine tumors | Q28301270 |
| Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers | Q34209006 | ||
| Clonal composition of benign and malignant human thyroid tumors | Q34255486 | ||
| Introduction of v-Ha-ras oncogene induces differentiation of cultured human medullary thyroid carcinoma cells | Q34340548 | ||
| Genetic basis of endocrine disease 3: Molecular defects in thyroid gland neoplasia | Q35596740 | ||
| High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas | Q35823973 | ||
| Signal transduction via the MAP kinases: proceed at your own RSK. | Q36381460 | ||
| Activation of the cyclic AMP cascade as an oncogenic mechanism: the thyroid example | Q37178964 | ||
| Evidence for and possible mechanisms of non-genotoxic carcinogenesis in the rodent thyroid | Q37751639 | ||
| Oncogenes and growth factors in thyroid carcinogenesis. | Q37901169 | ||
| Medullary carcinoma of the thyroid gland. Clinical, pathological, and immunohistochemical features with review of the literature. | Q38159580 | ||
| The G-protein family and their interaction with receptors | Q38287157 | ||
| The thyrotropin receptor (TSH-R) is not an oncogene for thyroid tumors: structural studies of the TSH-R and the alpha-subunit of Gs in human thyroid neoplasms | Q38318649 | ||
| gsp mutations in human thyroid tumours | Q38335860 | ||
| Activating point mutations of the gsp oncogene in human thyroid adenomas | Q38337366 | ||
| The molecular biology of medullary thyroid carcinoma. A model for cancer development and progression | Q38626994 | ||
| Nodular thyroid disease. Evaluation and management | Q39825459 | ||
| Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. | Q41019851 | ||
| Presence of mutations in all three ras genes in human thyroid tumors | Q41203275 | ||
| Ras-dependent activation of MAP kinase pathway mediated by G-protein beta gamma subunits. | Q41461969 | ||
| Low frequency of ras gene mutations in neuroblastomas, pheochromocytomas, and medullary thyroid cancers | Q41691073 | ||
| C-myc, N-myc, N-ras, and c-erb-B: lack of amplification or rearrangement in human medullary thyroid carcinoma and a derivative cell line. | Q41752179 | ||
| A pituitary specific point mutation of codon 201 of the Gs alpha gene in a pituitary adenoma of a patient with multiple endocrine neoplasia (MEN) type 1 | Q42149768 | ||
| Detection of the H-RAS oncogene in human thyroid anaplastic carcinomas | Q42798928 | ||
| The frequency of cold thyroid nodules and thyroid malignancies in patients from an iodine-deficient area | Q45092459 | ||
| Mutational activation of RAS and GSP oncogenes in differentiated thyroid cancer and their biological implications | Q46364978 | ||
| High rates of ras codon 61 mutation in thyroid tumors in an iodide-deficient area. | Q53498540 | ||
| Inactivation of the p53 gene is not required for tumorigenesis of medullary thyroid carcinoma or pheochromocytoma | Q55024513 | ||
| ras mutations in endocrine tumors: mutation detection by polymerase chain reaction-single strand conformation polymorphism | Q55417795 | ||
| A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma | Q55670928 | ||
| Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC | Q57591365 | ||
| Hyperthyroidism and thyroid cancer | Q67928062 | ||
| Ras oncogene mutations in benign and malignant thyroid neoplasms | Q67970594 | ||
| High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma | Q69398273 | ||
| High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis | Q69490865 | ||
| Thyroid carcinoma after exposure to atomic radiation. A continuing survey of a fixed population, Hiroshima and Nagasaki, 1958-1971 | Q69754723 | ||
| Analysis of the Gs alpha gene in growth hormone-secreting pituitary adenomas by the polymerase chain reaction-direct sequencing method using paraffin-embedded tissues | Q72598967 | ||
| Rare mutations of the Gs alpha subunit gene in human endocrine tumors. Mutation detection by polymerase chain reaction-primer-introduced restriction analysis | Q72851763 | ||
| Gross and microscopic findings in clinically normal thyroid glands | Q73826422 | ||
| P433 | issue | 8 | |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 737-742 | |
| P577 | publication date | 1995-08-01 | |
| P1433 | published in | Japanese Journal of Cancer Research | Q26842384 |
| P1476 | title | Point mutations of ras and Gs alpha subunit genes in thyroid tumors. | |
| P478 | volume | 86 |
| Q41388828 | Molecular insights into TSH receptor abnormality and thyroid disease |
| Q53924472 | Neoplastic non-papillary thyroid carcinoma lesions with a fine chromatin pattern. |
| Q74023992 | Non-hyperfunctioning nodules from multinodular goiters: a minor role in pathogenesis for somatic activating mutations in the TSH-receptor and Gsalpha subunit genes |
| Q26796901 | RAS proto-oncogene in medullary thyroid carcinoma |
| Q62930171 | Role of ras mutation in the progression of thyroid carcinoma of follicular epithelial origin |
| Q36293540 | Somatic RAS mutations occur in a large proportion of sporadic RET-negative medullary thyroid carcinomas and extend to a previously unidentified exon. |
| Q38614485 | Thyroid C-Cell Biology and Oncogenic Transformation. |
| Q77687816 | Thyroid follicular oncogenesis in iodine-deficient and iodine-sufficient areas: search for alterations of the ras, met and bFGF oncogenes and of the Rb anti-oncogene |
Search more.